ArticleJournal of hematology & oncology2021

Targeting the metabolic vulnerability of acute myeloid leukemia blasts with a combination of venetoclax and 8-chloro-adenosine.

Ralf Buettner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.